Invention Application
- Patent Title: BICYCLIC PYRAZOLE BRUTON'S TYROSINE KINASE INHIBITORS
-
Application No.: US17552396Application Date: 2021-12-16
-
Publication No.: US20220213092A1Publication Date: 2022-07-07
- Inventor: David A. DeGoey , Felix DeAnda, Jr. , Amanda W. Dombrowski , Igor Dubovyk , Stephen N. Greszler , Dimitri Khrakovsky , Chih-Hung Lee , James N. Newton , Elizabeth L. Noey , Akinori Okano , Kevin B. Sippy , Andrew J. Souers , Longcheng Wang , Noel S. Wilson , Jeffery A. Zablocki
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00 ; C07D487/04
Abstract:
The present invention provides for compounds of formula (I) wherein A, R1, R2, R4, W, m, and n have any of the values defined herein, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of CLL and/or SLL.
Information query
